First Biosimilar Approved for Neovascular Age-Related Macular Degeneration (nAMD)
AMD is a common eye condition and a leading cause of vision loss among people aged 50 and older. nAMD accounts for almost 90% of blindness associated with AMD....
Our articles provide quick read summaries to help keep you informed and looking forward with industry insights.
AMD is a common eye condition and a leading cause of vision loss among people aged 50 and older. nAMD accounts for almost 90% of blindness associated with AMD....
Choosing an ophthalmology clinical trial endpoint services partner can be a labor-intensive and lengthy process. Do you ever wonder if you’re asking the right questions in your selection process?...
In today’s rapidly consolidating contract research organization (CRO) market, it’s important to be sure you’re partnering with the right company to provide you with the expert clinical trial endpoint services you need to advance your drug program....
MERIT’s CEO, Yijun Huang, PhD., shares his perspective about how big data impacts the pharma industry and the field of ophthalmology clinical trial research specifically. Read our article to discover three ways AI can assist in the field of image analysis for clinical trials....
Chronic lung disease, such as COPD, has higher rates in underserved communities such as minority and rural areas. Yet less than 5% of industry-sponsored respiratory-related clinical trials have reported racial or ethnic backgrounds....
[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern"][vc_column][vc_column_text]Clinical endpoint service providers offer a specific set of research services that revolve around a particular stage of clinical development or therapeutic area(s). Most providers increase value by helping you gain efficiencies and by providing deep scientific expertise...
[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern"][vc_column][vc_column_text css=".vc_custom_1646757938615{padding-bottom: 50px !important;}"] Remote Spirometry Insights Interest in virtual trials and remote spirometry greatly increased with the COVID-19 pandemic. As subjects were less able to attend in-clinic visits due to stay-at-home orders and concerns about spread of the disease,...
Partly in response to potential inhaler shortages arising due to treatment of COVID-19, the U.S. Food and Drug Administration (FDA) approved the first generic version of Proventil HFA (albuterol sulfate) in the U.S. in April 2020. Dr. Stephen Hahn of the FDA, commented in a...
Part 2 of Optical Coherence Tomography (OCT) technology measurement of retinal thickening in the macular region. several technical challenges must be overcome....
OCT technology provides objective measurement of retinal thickening in the macular region. However, for the resultant data to be considered reliable, and to be incorporated into a regulatory submission, several technical challenges must be overcome....